Entera Bio (NASDAQ:ENTX) Trading Up 2%

Entera Bio Ltd. (NASDAQ:ENTX)’s share price was up 2% on Wednesday . The stock traded as high as $2.04 and last traded at $2.00. Approximately 70,571 shares traded hands during mid-day trading, a decline of 66% from the average daily volume of 208,336 shares. The stock had previously closed at $1.96.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reiterated a “buy” rating and set a $10.00 price objective on shares of Entera Bio in a research note on Tuesday, April 2nd.

Entera Bio Stock Performance

The company has a 50 day simple moving average of $1.73 and a 200 day simple moving average of $1.10. The company has a market capitalization of $57.60 million, a PE ratio of -6.45 and a beta of 1.70.

Entera Bio (NASDAQ:ENTX) last posted its quarterly earnings data on Friday, March 8th. The company reported ($0.07) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.01. As a group, equities research analysts anticipate that Entera Bio Ltd. will post -0.25 EPS for the current year.

About Entera Bio

Entera Bio Ltd., a clinical-stage company, focuses on the development and commercialization of orally delivered peptide and protein therapeutics for unmet medical needs. The company's product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of stress fractures.